The previous page is sending you to https://www.prnewswire.com/news-releases/delpors-investigational-risperidone-implant-product-provides-schizophrenia-therapy-for-up-to-one-year-after-a-single-administration-in-phase-1b2a-patient-study-301990628.html.

 If you do not want to visit that page, you can return to the previous page.